Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
584.65
Change Change %
-1.65 -0.28%

Updated:25 Jun, 2019, 12:49 PM IST

BSE
585.15
Change Change %
-1.05 -0.18%

Updated:25 Jun, 2019, 12:57 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Credit Suisse
N/A
03-05-2016 Buy 792.20 950.00
N/A
Closed Long (1Y)
03-05-2017

Credit Suisse maintains outperform on Aurobindo Pharma

Company will be a beneficiary of faster approvals in US. Margin expansion will be driven by improving product mix. Expect 38 per cent profit growth over next 2 quarters. Expect operating profit CAGR of 22 per cent over FY2016-18. Auro Pharma is favourably placed on growth and return against its peers.

Top